Orantinib T6184
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
TSU-68, a excellent effective against PDGFR autophosphorylation with Ki of 8 nM, also highly inhibits Flk-1 and FGFR1 trans-phosphorylation. It shows little effect against IGF-1R, Met, Src, Lck, Zap70, Abl and CDK2 and does not suppresses EGFR.
CAS nr:
252916-29-3
Purity:
98%
Molecular Weight:
310,35
SMILES:
Cc1[nH]c(\C=C2/C(=O)Nc3ccccc23)c(C)c1CCC(O)=O
Formula:
C18H18N2O3
Pathway:
Angiogenesis,Tyrosine Kinase/Adaptors,Angiogenesis,Tyrosine Kinase/Adaptors,Tyrosine Kinase/Adaptors,Angiogenesis,Apoptosis
Target:
PDGFR,PDGFR,VEGFR,VEGFR,FGFR,FGFR,Apoptosis
